Bracco Group

Feb 06, 2025

Bracco Imaging Receives FDA Fast Track Designation for BR55, Ultrasound Molecular Imaging Agent for the Detection of Active Bowel Inflammation in Crohn's Disease

Dec 02, 2024

Bracco Diagnostics Inc. Branded Max 3(TM), a Rapid Exchange and Syringeless Injector, received FDA 510(k) clearance adding evolving innovation in Magnetic Resonance Imaging (MRI) and its product portfolio

Nov 20, 2024

ColoWatch® and Bracco Diagnostics Inc. Announce Partnership to Expand the Availability of Virtual Colonoscopy for the Early Detection of Colon and Rectal Cancer

Nov 11, 2024

Bracco Diagnostics Inc. Obtains Hallmark Achievement of One Million Injections with its MRI agent VUEWAY® (gadopiclenol) solution for injection

Mar 19, 2024

Samsung Medison and Bracco Imaging Forge Path with New Diagnostic Ultrasound Technology Agreement at ECR 2024

Jul 09, 2020

ACIST Medical Systems Announces Launch of the Latest Advance in FFR Microcatheters

Apr 27, 2020

Bracco Launches Global "BRACCO CARES" Initiative to Support Healthcare Professionals Through Trying Times